Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (7): 63-71.doi: 10.6040/j.issn.1671-7554.0.2023.0013

• 临床医学 • Previous Articles    

Attitudes and practices of respiratory physicians regarding the diagnosis and treatment of bronchiectasis: a questionnaire-based cross-sectional study in Shandong Province, China

QI Qian1,2*, HAO Tianyu1*, XU Jiawei1, WANG Guanghai1, WU Fengjuan3, LIU Mingtao4, JIANG Peng5, DONG Liang1, LI Yu6   

  1. 1. Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University &
    Shandong Provincial Qianfoshan Hospital, Jinan 250014, Shandong, China;
    2. Department of Respiratory, Shandong Provincial Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China;
    3. Department of Respiratory, Heze Municipal Hospital, Heze 274000, Shandong, China;
    4. Department of Respiratory, Binzhou Peoples Hospital, Binzhou 256600, Shandong, China;
    5. Department of Respiratory, Weihai Municipal Hospital, Weihai 264200, Shandong, China;
    6. Department of Respiratory, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2023-07-04

PDF (PC)

123

Abstract: Objective To evaluate the attitudes and practices of respiratory physicians regarding the diagnosis and treatment of bronchiectasis, so as to provide reference for promoting the management strategies of bronchiectasis. Methods During Oct. 2020 and Jun. 2022, a questionnaire survey was conducted among respiratory physicians in 143 hospitals in Shandong Province about the cognition of diagnosis and treatment of bronchiectasis. The cognitive status of physicians at different levels of hospitals and with different professional titles were compared. Results A total of 608 respiratory physicians completed the questionnaire, 24.7% of whom never tested humoral immunity, and 27.6% knew about the Bronchiectasis Severity Index. The cognition of bronchiectasis etiology discrimination and Pseudomonas aeruginosa clearance of physicians from tertiary hospitals was significantly higher than that of those from secondary hospitals(OR=1.952, 95%CI: 1.253-3.041, P=0.003; OR=2.495, 95%CI: 1.543-4.035, P<0.001). Physicians who had read the bronchiectasis guidelines had a higher cognition than those who had not read the guidelines(OR=1.725, 95%CI: 1.027-2.897, P=0.039; OR=2.067, 95%CI: 1.361-3.138, P=0.001). Conclusion The cognition of bronchiectasis management strategies among respiratory physicians, especially those from secondary hospitals in Shandong Province, still needs to be strengthened. It is necessary to continue to promote etiological screening and simplified disease severity assessment methods.

Key words: Bronchiectasis, Respiratory physicians, Questionnaire survey, Cognition, Disease management

CLC Number: 

  • R562
[1] Sin S, Yun SY, Kim JM, et al. Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis [J]. Respir Res, 2019, 20(1): 271. doi: 10.1186/s12931-019-1243-3.
[2] Diel R, Ewig S, Blaas S, et al. Incidence of patients with non-cystic fibrosis bronchiectasis in Germany-A healthcare insurance claims data analysis [J]. Respir Med, 2019, 151: 121-127. doi: 10.1016/j.rmed.2019.04.007.
[3] Choi H, Yang B, Nam H, et al. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea [J]. Eur Respir J, 2019, 54(2): 1900194. doi: 10.1183/13993003.00194-2019.
[4] 周玉民, 王辰, 姚婉贞, 等. 我国7省市城区40岁及以上居民支气管扩张症的患病情况及危险因素调查[J]. 中华内科杂志, 2013, 52(5): 379-382. ZHOU Yumin, WANG Chen, YAO Wanzhen, et al. The prevalence and risk factors of bronchiectasis of residents aged 40 years old and above in seven cities in China [J]. Chinese Journal of Internal Medicine, 2013, 52(5): 379-382.
[5] Hill AT, Sullivan AL, Chalmers JD, et al. British Thoracic Society guideline for bronchiectasis in adults [J]. Thorax, 2019, 74(Suppl 1): 1-69.
[6] Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis [J]. Eur Respir J, 2017, 50(3): 1700629. doi: 10.1183/13993003.00629-2017.
[7] Chang AB, Fortescue R, Grimwood K, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis [J]. Eur Respir J, 2021, 58(2): 2002990. doi: 10.1183/13993003.02990-2020.
[8] Martinez-Garcia MA, Maiz L, Olveira C, et al. Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults [J]. Arch Bronconeumol, 2018, 54(2): 79-87.
[9] Martinez-Garcia MA, Maiz L, Olveira C, et al. Spanish guidelines on treatment of bronchiectasis in adults [J]. Arch Bronconeumol, 2018, 54(2): 88-98.
[10] 成人支气管扩张症诊治专家共识编写组. 成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志, 2012, 35(7): 485-492.
[11] 支气管扩张症专家共识撰写协作组, 中华医学会呼吸病学分会感染学组. 中国成人支气管扩张症诊断与治疗专家共识[J]. 中华结核和呼吸杂志, 2021, 44(4): 311-321. Bronchiectasis Expert Consensus Writing Group, Pulmonary Infection Assembly, Chinese Thoracic Society. Expert consensus on the diagnosis and treatment of adult bronchiectasis in China [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(4): 311-321.
[12] Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study [J]. Am J Respir Crit Care Med, 2014, 189(5): 576-585.
[13] Choate R, Aksamit TR, Mannino D, et al. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score(BSI)and the FACED: the US bronchiectasis and NTM Research Registry(BRR)study [J]. Respir Med, 2020, 177: 106285. doi: 10.1016/j.rmed.2020.106285.
[14] Martinez-Garcia MA, Athanazio RA, Girón R, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score [J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 275-284. doi: 10.2147/COPD.S121943.
[15] Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis [J]. Respir Med, 2007, 101(6): 1163-1170.
[16] McShane PJ, Naureckas ET, Strek ME. Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture [J]. Chest, 2012, 142(1): 159-167.
[17] Eastham KM, Fall AJ, Mitchell L, et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood [J]. Thorax, 2004, 59(4): 324-327.
[18] Qi Q, Wang W, Li T, et al. Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: a prospective study [J]. Respirology, 2015, 20(6): 917-924.
[19] Guan W, Gao Y, Xu G, et al. Aetiology of bronchiectasis in Guangzhou, southern China [J]. Respirology, 2015, 20(5): 739-748.
[20] Gupta S, Pattanaik D, Krishnaswamy G. Common variable immune deficiency and associated complications [J]. Chest, 2019, 156(3): 579-593.
[21] 王宁, 徐金富. 欧洲成人支气管扩张症管理指南带给我们的思考[J]. 中华结核和呼吸杂志, 2019, 42(2): 153-156.
[22] 徐金富, 柴燕华. 支气管扩张症患者下呼吸道分离出铜绿假单胞菌的临床意义和对策[J]. 中华结核和呼吸杂志, 2019, 42(7): 506-509. XU Jinfu, CHAI Yanhua. Clinical implication and management of Pseudomonas aeruginosa colonization in patients with bronchiectasis [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2019, 42(7): 506-509.
[23] White L, Mirrani G, Grover M, et al. Outcomes of pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis [J]. Respir Med, 2012, 106(3): 356-360.
[24] Durfey SL, Pipavath S, Li A, et al. Combining ivacaftor and intensive antibiotics achieves limited clearance of cystic fibrosis infections [J]. mBio, 2021, 12(6): e0314821. doi: 10.1128/mbio.03148-21.
[25] Kaehne A, Milan SJ, Felix LM, et al. Head-to-head trials of antibiotics for bronchiectasis[J]. Cochrane Database Syst Rev, 2018, 9(9): CD012590. doi: 10.1002/14651858.CD012590.pub2.
[26] Hernando R, Drobnic ME, Cruz MJ, et al. Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis [J]. Int J Clin Pharm, 2012, 34(4): 644-650.
[27] Martinez-Garcia MA, Soler-Cataluna JJ, Catalan-Serra P, et al. Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis [J]. Chest, 2012, 141(2): 461-468.
[28] Goyal V, Chang AB. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis [J]. Cochrane Database Syst Rev, 2014, 2014(6): CD010327. doi: 10.1002/14651858.CD010327.pub2.
[29] Kapur N, Petsky HL, Bell S, et al. Inhaled corticosteroids for bronchiectasis [J]. Cochrane Database Syst Rev, 2018, 5(5): CD000996. doi: 10.1002/14651858.CD000996.pub3.
[30] Shoemark A, Shteinberg M, De Soyza A, et al. Characterisation of eosinophilic bronchiectasis: a European multicohort study [J]. Am J Respir Crit Care Med, 2022, 205(8): 894-902.
[31] 王玲, 师一涵, 杨恒, 等. 支气管扩张症年度进展2021 [J]. 中华结核和呼吸杂志, 2022, 45(6): 592-597. WANG Ling, SHI Yihan, YANG Heng, et al. Annual review of bronchiectasis in 2021 [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2022, 45(6): 592-597.
[1] CHEN Bingrong, SHI Yongwang, LI Jiahao, ZHAI Jiliang, LIU Liang, LIU Wenyong, HU Lei, ZHAO Yu. Electrical impedance recognition of spine tissue in vitro based on support vector machine [J]. Journal of Shandong University (Health Sciences), 2023, 61(3): 57-62.
[2] WANG Lumin, ZHOU Shiying, HUANG Qikun, LIU Yanli. A case of primary ciliary dyskinesia caused by a novel DNAH5 gene mutation [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 103-108.
[3] WANG Kefang, WU Chen. Dilemmas and thoughts on solutions of adherence to chronic disease management [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 124-129.
[4] HUANG Xiuli, LIU Bingju, SUN Lifeng. Activated phosphoinositide 3-kinase δ syndrome caused by a mutation in PIK3CD gene: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 107-112.
[5] LIU Xinyu, WANG Quan, JU Haojie, SUN Xiaojie. Mediating effect of cognition on the relationship between social capital and functional health of elderly people [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 100-107.
[6] Jizong ZHAO. Neurosurgery plays a key role in brain science research [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 1-4.
[7] XUE Fuzhong. Healthcare big data-driven theory and methodology for health management [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 1-29.
[8] SHANG Yuying, MA Yingjuan, WU Xiaofan, HOU Xunyao, LUO Dingzhen, CHEN Jian, HONG Yan, SHEN Chao, LIU Xueping. Synapse-protective effect of flavonoids extracted from the leaves of Diospyros kaki in APP/PS1 transgenic mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 33-37.
[9] QI Qian, WANG Wen, LI Tao, LI Yu. Clinical evaluation of adult patients with bronchiectasis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 68-72.
[10] L Qing-tao1, ZHONG Xiao-ning2, RONG Rong1, ZHANG Zhao-wang1, SUN Xiu-mei1. HPLC fingerprint-pattern recognition of Yigan granules [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 68-72.
[11] LI Zhe1, YANG Ping2. Cognition level of law of the medical staff in Weihai and its related factors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 115-119.
[12] LI Zhe1, YANG Ping2. Cognition level of law of the medical staff in Weihai and its related factors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 115-119.
[13] JIANG Hai-qiang1, LI Yun-lun2, XIE Jun2. Plasma metabonomic study on hypertension by high performance liquid chromatography coupled with time of flight mass spectrometry [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(10): 150-.
[14] WANG De-wei, XIE Zhao-hong, LAI Chao, ZHU Zheng-yu, WANG Yun, JIN Su-qin， BI Jian-zhong. Preliminary application of Montreal cognitive assessment in vascular cognitive impairment [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(9): 97-.
[15] KONG Min， GAO Yuxing. Effect of antiepileptic drugs on cognitive functions and expressions of glutamate receptor 2 and synaptophysin of the hippocampus in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(7): 14-18.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd